5 minutes to stay current | |
Shirley M, et al. – In this study, the authors demonstrate that aripiprazole LAI is a valuable new treatment option for adult patients with schizophrenia. It may be of particular use for patients stable on oral aripiprazole who would prefer, or are likely to benefit from, a long–acting formulation.
Receive more summaries like this by joining MDLinx. We provide free daily digests of top journal articles in your field. >> Click here to choose your specialties.
|
|
|
HOME
(*Revenire-Pagina la Zi)
MENU
EDITORIAL
-
I. DIAGNOSIS
- II. T H E R A P Y
- B.PSYCHOTHERAPY
- _B.a.CULTURE
- III. ADMINISTRATIVE
- IV. LEGISLATION
No comments:
Post a Comment